Received Feb 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | TX77L | — |
16 day old receiving a infanrix vaccine; Administered Infanrix instead of hepatitis B vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 16-day-old male patient who received DTPa (Infanrix) (batch number TX77L, expiry date 01-DEC-2025) for prophylaxis. Co-suspect products included HBV (Engerix B) for prophylaxis. On 21-FEB-2025, the patient received Infanrix. On an unknown date, the patient received Engerix B. On 21-FEB-2025, an unknown time after receiving Infanrix and not applicable after receiving Engerix B, the patient experienced inappropriate age at vaccine administration (Verbatim: 16 day old receiving a infanrix vaccine) and wrong vaccine administered (Verbatim: Administered Infanrix instead of hepatitis B vaccine). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 21-FEB-2025 Other HCP started a 16 day old receiving a Infanrix vaccine. According to reporter, the dose was administered earlier that day. Reporter had a 16 days old baby that received Infanrix instead of the Hepatitis B, Engerix-B, which led to wrong vaccine administered. Reporter need to know what they need to do for this child. 16 day old receiving a Infanrix vaccine, which led to inappropriate age at vaccine administration.